Why the study?
Does preoperative statin therapy improve early conversion rates to sinus rhythm in patients with atrial fibrillation undergoing concomitant cardiac surgery and surgical ablation?
Does preoperative statin therapy improve early conversion rates to sinus rhythm in patients with atrial fibrillation undergoing concomitant cardiac surgery and surgical ablation?
Preoperative statin therapy does not improve early sinus rhythm conversion rates or reduce inflammation in patients undergoing surgical ablation for atrial fibrillation during concomitant cardiac surgery.
Answers are grounded in this paper and cite their sources.
Preoperative statin use was not associated with improved sinus rhythm maintenance; leaves open the role of statins in surgical AF ablation.
Aims: Statin use reduces the incidence of atrial fibrillation (AF) after cardiac surgery through anti-inflammatory effects. We hypothesized that statin use prior to surgical ablation for AF during concomitant cardiac procedures can improve early ablation outcomes. Methods: One-hundred patients (69±10 years;69% men) with paroxysmal (34%) or permanent (66%) AF undergoing cardiac surgery (CABG 55%, valve surgery 65% and aortic surgery 4%) and surgical ablation were retrospectively analyzed. Applied energy sources for AF ablation were radiofrequency (84%) and ultrasound (16%). Fifty patients (50%) were on preoperative statins (statin group) before surgery. Early conversion rates to SR (OR, ICU, hospital discharge, 3 months), freedom from anti-arrhythmic therapy and pro-inflammatory C-reactive protein (CRP) levels were recorded. Results: Intraoperative conversion rate to SR was 92% and 94% in statin and control patients. SR was preserved in 82% vs. 80% of patients at ICU, 52% vs. 56% at discharge and 55% vs. 62% at 3 months in statin pretreated and control patients (p=n.s). Similarly, there was no difference in electrical cardioversion rates (8% control vs. 16% statins) and freedom from antiarrhythmic therapy (56% control vs. 42% statins) between treatment groups. Preoperative statin use was not linked to reduced CRP levels after surgical ablation (maximal CRP 165±68 (control) vs. 177±67mg/dl (statin); p=n.s.). Conclusions: Our data suggests that preoperative statin therapy is not associated with improved early ablation outcome in patients undergoing cardiac surgery with surgical ablation for AF. Data from RCT with extended follow-up periods are needed to allow definite conclusions.
No takes yet. Share an insight, caveat, or question.
Liakopoulos et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: